Kinapse Joins the Pistoia Alliance
Becoming the latest of over 90 other life sciences companies to join the global, not-for-profit alliance
Kinapse, a market leading advisory and operational solutions provider to the global life sciences industry, has joined the Pistoia Alliance, a global, not-for-profit alliance of life science companies, vendors, publishers, and academic groups that work together to lower barriers to innovation in Research and Development.
Joining an alliance of 90 other members (as of November 2018) Kinapse will now be privy to benefits such as more open collaboration with Life Science R&D peers and key vendors, member-only meetings, receptions and network events, and cross-company work streams.
Dr Steve Arlington, President of The Pistoia Alliance had the following to say:
“We are very pleased to welcome Kinapse into The Pistoia Alliance, and look forward to working with them to achieve our goal of lowering barriers to innovation in the life science industry. The world of life sciences R&D continues to change rapidly – and sharing, partnering and collaborating will be essential to increased innovation. As our membership continues to grow, our projects and initiatives will be vital in fostering this collaborative mind-set and leading to new breakthroughs,”
About the Pistoia Alliance
Named after the city in which they were founded, The Pistoia Alliance are a global, not-for-profit alliance of life science companies, vendors, publishers, and academic groups that work together to lower barriers to innovation in R&D.
Their projects transform R&D innovation through pre-competitive collaboration. They bring together the key constituents to identify the root causes that lead to R&D inefficiencies. They develop best practices and technology pilots to overcome common obstacles. Learn more at PistoiaAlliance.org
Kinapse, a Syneos Health company, is a leading advisory and operational solutions provider to the global life sciences industry. The Company delivers its services across the full clinical and commercialization continuum and across global markets, collaborating with its biopharmaceutical customers to improve patients’ lives. Through a unique Advise – Build – Operate Model, Kinapse delivers quantifiable business benefits and operational success. Headquartered in the UK, Kinapse has over 600 staff located in Europe, India and the U.S. Learn more at Kinapse.com
Download white paper
Managing Performance in Patient Centricity:
Making the link between value for patients and value for the pharmaceutical industry